Venture&Growth
Location
Barcelona, Spain 
Venture&Growth
All Portfolio items
See full Venture&Growth portfolio
Splice Bio is a biotech company based on intein technologies developed in the Muir Lab at Princeton University. They are working with their proprietary platform to address key limitations of current gene therapy approaches to treat patients in need. The company is building a product pipeline of gene therapies targeting inherited retinal diseases and other severe genetic diseases for which there is no cure.
More Splice Bio news
Gilde Healthcare invests in Eur 50M series A round of Spanish Gene Therapy company SpliceBio
AM-Pharma
AM-Pharma is a Dutch biopharmaceutical company developing a biotherapeutic for the treatment of Sepsis Associated...
Vapotherm
US-based MedTech company commercializing oxygen therapy for patients in respiratory distress.
Proverum
Proverum is an Irish medical device company founded in 2016 as a spin-off from Trinity...
